SERMORELIN nothing more. nothing less.
Sermorelin is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH 1-29). Studied in research involving GH axis stimulation, neuroendocrine signaling, and age-related hormone decline.
Purity >99%Form Lyophilized PowderNo Endotoxins
Order within
—
Notify me when back in stock
For research use only — not for human consumption, therapeutic, or diagnostic use. By adding to cart you acknowledge these terms.
Blank. Credentials
Institutional-grade credentials you can verify
About This Compound
Deep technical insights for clinical research
Primary Research Applications
This compound is supplied strictly for in-vitro and preclinical research use only. Primary applications include the areas below.
Serves as a diagnostic agent to assess growth hormone secretion and identify growth hormone deficiency with high specificity.
Restores pulsatile growth hormone secretion patterns through selective GHRH receptor stimulation on pituitary somatotrophs.
Research Community Feedback
"Consistency is paramount in our cellular model testing. Blank's peptides have maintained the tightest purity specs of any RUO vendor we've audited."
Dr. Julian Kessler
Lead Investigator, Biomatrix Labs
"The availability of detailed MS and HPLC data on the product page saved us two days of redundant internal verification. Professional grade synthesis."
Anika S. Singh
Synthetics Quality Control
"Finally, a supplier that doesn't hide behind consumer marketing. Stark, clear, and high-purity. Exactly what a modern lab needs."
Prof. David Emmerich
Applied Peptide Research
Complete The Protocol
Pairs & Supplies
The compounds and tools researchers stack with SERMORELIN.
Peer-Reviewed Literature
Related Studies
Endocrine and Metabolic Effects of Long-Term Administration of Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women
Journal of Clinical Endocrinology & Metabolism
5-month trial demonstrated significant increases in skin thickness and lean body mass in males receiving nightly subcutaneous sermorelin injections with improved wellbeing markers.
Sermorelin: A Better Approach to Management of Adult-Onset Growth Hormone Insufficiency?
Clinical Interventions in Aging
Comprehensive analysis proposing sermorelin as preferable to recombinant GH for growth hormone replacement, highlighting its advantage of maintaining physiological GH pulsatility.
Beyond the Androgen Receptor: The Role of Growth Hormone Secretagogues in the Modern Management of Body Composition
Translational Andrology and Urology
Review documenting GHS effects on lean mass, adiposity reduction, and potential adjunctive therapy for hypogonadism with comparable fat loss to recombinant GH therapy.
A Two-Year, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Sermorelin (Geref Diagnostic)
Growth Hormone & IGF Research
Two-year open-label study in GH-deficient children demonstrated sermorelin maintained sustained increases in growth velocity, height SDS, and IGF-I without clinically significant adverse events or antibody development.
The Effect of GHRH Analog on Body Composition and Metabolic Parameters in HIV Lipodystrophy
Clinical Endocrinology
GHRH analog therapy reduced trunk fat by 6.2%, increased lean body mass by 1.3 kg, and improved lipid profiles in HIV patients with lipodystrophy over 12 weeks versus placebo.
Growth Hormone Releasing Hormone (GHRH) Neurons and GHRH-Neuron Subtypes in the Hypothalamus
Frontiers in Neuroendocrinology
Comprehensive mapping of GHRH neuronal circuits in the hypothalamus explaining why GHRH analogs like sermorelin preserve physiological pulsatility while exogenous GH replacement suppresses it.
From the Lab
Related Blog Posts
Feb 16, 2026
Peptide Stacking: Research Protocols, Combinations, and What the Science Says
“Stacking” is borrowed from the bodybuilding lexicon, but the underlying concept — combining compounds with complementary mechanisms — is standar...
Feb 9, 2026
Best Research Peptides in 2026: A Complete Guide by Category
The research peptide landscape in 2026 is broader than it’s ever been. What used to be a handful of compounds…
Jan 19, 2026
What Is Tesamorelin? Growth Hormone-Releasing Research for Body Composition
Tesamorelin is a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH) — and it holds a distinction almost no…